{
    "nctId": "NCT04669132",
    "briefTitle": "Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer",
    "officialTitle": "Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Nausea Post Chemotherapy",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Nausea Complete Response Rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer hitologically confirmed\n* 18 Years and older (Adult, Older Adult)\n* Patients about to start use of Doxorubicine 60mg/m2 + Cyclophosfamide 600mg/m2\n* No previous chemotherapy for breast cancer\n\nExclusion Criteria:\n\n* Patients not capable of completing the questionnaire\n* Patients with other condition that could cause nausea and emesis\n* Use of opioids\n* Use of antipsychotic medications\n* Patients not capable of taking medications orally",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}